{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:24:56Z","timestamp":1788186296951,"version":"build-2803163510"},"reference-count":146,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Antibiotic resistance is a serious global health problem that poses a threat to the successful treatment of various bacterial infections, especially those caused by methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE). Conventional treatment of MRSA and VRE infections is challenging and often requires alternative or combination therapies that may have limited efficacy, higher costs, and\/or more adverse effects. Therefore, there is an urgent need to find new strategies to combat antibiotic-resistant bacteria. Probiotics and antimicrobial peptides (AMPs) are two promising approaches that have shown potential benefits in various diseases. Probiotics are live microorganisms that confer health benefits to the host when administered in adequate amounts. AMPs, usually produced with probiotic bacteria, are short amino acid sequences that have broad-spectrum activity against bacteria, fungi, viruses, and parasites. Both probiotics and AMPs can modulate the host immune system, inhibit the growth and adhesion of pathogens, disrupt biofilms, and enhance intestinal barrier function. In this paper, we review the current knowledge on the role of probiotics and AMPs in targeting multi-drug-resistant bacteria, with a focus on MRSA and VRE. In addition, we discuss future directions for the clinical use of probiotics.<\/jats:p>","DOI":"10.3390\/microorganisms11102393","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T02:31:29Z","timestamp":1695695489000},"page":"2393","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Probiotics and Their Bioproducts: A Promising Approach for Targeting Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6365-8411","authenticated-orcid":false,"given":"Manav","family":"Jain","sequence":"first","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Pediatrics, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT 84108, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5269-214X","authenticated-orcid":false,"given":"Gideon","family":"Stitt","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Pediatrics, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT 84108, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Son","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Pediatrics, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT 84108, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Y.","family":"Enioutina","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Pediatrics, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT 84108, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis","volume":"399","year":"2022","journal-title":"Lancet"},{"key":"ref_2","unstructured":"Centers for Disease Control and Prevention (2019). Antibiotic Resistance Threats in the United States, 2019."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","article-title":"Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: A population-level modelling analysis","volume":"19","author":"Cassini","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Palma, E., Tilocca, B., and Roncada, P. (2020). Antimicrobial Resistance in Veterinary Medicine: An Overview. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21061914"},{"key":"ref_5","first-page":"957","article-title":"Public health risk of antimicrobial resistance transfer from companion animals","volume":"72","author":"Pomba","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Tamma, P.D., Aitken, S.L., Bonomo, R.A., Mathers, A.J., van Duin, D., and Clancy, C.J. (2023). Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am., ciad428.","DOI":"10.1093\/cid\/ciad428"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/cid\/ciaa303","article-title":"Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists","volume":"71","author":"Rybak","year":"2020","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical Practice Guidelines by the Infectious Diseases Society ofAmerica for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)","volume":"28","author":"Paul","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_10","unstructured":"FAO, and WHO (2001). Evaluation of Health and Nutritional Properties of Powder Milk and Live Lactic Acid Bacteria."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1002\/jcph.1121","article-title":"Probiotics in Disease Prevention and Treatment","volume":"58","author":"Liu","year":"2018","journal-title":"J. Clin. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1093\/cid\/civ085","article-title":"Risk and safety of probiotics","volume":"60","author":"Doron","year":"2015","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/19490976.2017.1345414","article-title":"Using probiotics in clinical practice: Where are we now? A review of existing meta-analyses","volume":"8","author":"Rondanelli","year":"2017","journal-title":"Gut Microbes"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/01635581.2016.1158300","article-title":"The Potential Role of Probiotics in Cancer Prevention and Treatment","volume":"68","author":"Yu","year":"2016","journal-title":"Nutr. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/CCO.0000000000000342","article-title":"Probiotics-mediated suppression of cancer","volume":"29","author":"So","year":"2017","journal-title":"Curr. Opin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Devaraj, N.K., Suppiah, S., Veettil, S.K., Ching, S.M., Lee, K.W., Menon, R.K., Soo, M.J., Deuraseh, I., Hoo, F.K., and Sivaratnam, D. (2019). The Effects of Probiotic Supplementation on the Incidence of Diarrhea in Cancer Patients Receiving Radiation Therapy: A Systematic Review with Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials. Nutrients, 11.","DOI":"10.3390\/nu11122886"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1007\/s12602-019-09611-z","article-title":"Immunomodulatory Effect of Lactobacillus casei in a Murine Model of Colon Carcinogenesis","volume":"12","author":"Santerre","year":"2020","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s41043-022-00318-6","article-title":"The role of probiotics in the treatment of adult atopic dermatitis: A meta-analysis of randomized controlled trials","volume":"41","author":"Umborowati","year":"2022","journal-title":"J. Health Popul. Nutr."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Nath, A., Moln\u00e1r, M.A., Csighy, A., K\u0151szegi, K., Galambos, I., Husz\u00e1r, K.P., Koris, A., and Vatai, G. (2018). Biological Activities of Lactose-Based Prebiotics and Symbiosis with Probiotics on Controlling Osteoporosis, Blood-Lipid and Glucose Levels. Medicina, 54.","DOI":"10.3390\/medicina54060098"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrmicro2297","article-title":"Host interactions of probiotic bacterial surface molecules: Comparison with commensals and pathogens","volume":"8","author":"Lebeer","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"616713","DOI":"10.3389\/fimmu.2021.616713","article-title":"Modulatory Effects of Probiotics During Pathogenic Infections With Emphasis on Immune Regulation","volume":"12","author":"Raheem","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.4049\/jimmunol.1403169","article-title":"No vacancy: How beneficial microbes cooperate with immunity to provide colonization resistance to pathogens","volume":"194","author":"Raffatellu","year":"2015","journal-title":"J. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"\u017b\u00f3\u0142kiewicz, J., Marzec, A., Ruszczy\u0144ski, M., and Feleszko, W. (2020). Postbiotics\u2014A Step Beyond Pre- and Probiotics. Nutrients, 12.","DOI":"10.3390\/nu12082189"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Chen, C.H., and Lu, T.K. (2020). Development and Challenges of Antimicrobial Peptides for Therapeutic Applications. Antibiotics, 9.","DOI":"10.3390\/antibiotics9010024"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Zimina, M., Babich, O., Prosekov, A., Sukhikh, S., Ivanova, S., Shevchenko, M., and Noskova, S. (2020). Overview of Global Trends in Classification, Methods of Preparation and Application of Bacteriocins. Antibiotics, 9.","DOI":"10.3390\/antibiotics9090553"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Bin Hafeez, A., Jiang, X., Bergen, P.J., and Zhu, Y. (2021). Antimicrobial Peptides: An Update on Classifications and Databases. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222111691"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/18755305MTAwENDE80","article-title":"Mini Review on Antimicrobial Peptides, Sources, Mechanism and Recent Applications","volume":"27","author":"Boparai","year":"2020","journal-title":"Protein Pept. Lett."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa1914433","article-title":"Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012\u20132017","volume":"382","author":"Jernigan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Cairns, K.A., Udy, A.A., Peel, T.N., Abbot, I.J., Dooley, M.J., and Peleg, A.Y. (2023). Therapeutics for Vancomycin-Resistant Enterococcal Bloodstream Infections. Clin. Microbiol. Rev., 36.","DOI":"10.1128\/cmr.00059-22"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","article-title":"Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications","volume":"132","author":"Baddour","year":"2015","journal-title":"Circulation"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"10-1128","DOI":"10.1128\/AAC.02074-19","article-title":"Impact of Daptomycin Dose Exposure Alone or in Combination with \u03b2-Lactams or Rifampin against VancomycinResistant Enterococci in an In Vitro Biofilm Model","volume":"64","author":"Jahanbakhsh","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/cid\/ciu027","article-title":"DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?","volume":"58","author":"Roberts","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Legg, A., Carmichael, S., Chai, M.G., Roberts, J.A., and Cotta, M.O. (2023). Beta-Lactam Dose Optimisation in the Intensive Care Unit: Targets, Therapeutic Drug Monitoring and Toxicity. Antibiotics, 12.","DOI":"10.3390\/antibiotics12050870"},{"key":"ref_34","unstructured":"CDC (2023, May 01). COVID-19: U.S. Impact on Antimicrobial Resistance, Available online: https:\/\/www.cdc.gov\/drugresistance\/covid19.html."},{"key":"ref_35","first-page":"525","article-title":"Antibiotic therapy for pan-drug-resistant infections","volume":"30","author":"Ozma","year":"2022","journal-title":"Infez. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijfoodmicro.2007.02.023","article-title":"Specific Bifidobacterium strains isolated from elderly subjects inhibit growth of Staphylococcus aureus","volume":"117","author":"Lahtinen","year":"2007","journal-title":"Int. J. Food Microbiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12602-012-9093-z","article-title":"Antagonistic Action of Lactobacilli and Bifidobacteria in Relation to Staphylococcus aureus and Their Influence on the Immune Response in Cases of Intravaginal Staphylococcosis in Mice","volume":"4","author":"Lazarenko","year":"2012","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41586-018-0616-y","article-title":"Pathogen elimination by probiotic Bacillus via signalling interference","volume":"562","author":"Piewngam","year":"2018","journal-title":"Nature"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12602-019-09623-9","article-title":"Bacteriocin of Pediococcus acidilactici HW01 Inhibits Biofilm Formation and Virulence Factor Production by Pseudomonas aeruginosa","volume":"12","author":"Lee","year":"2020","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"281","DOI":"10.23736\/S0026-4806.20.06810-X","article-title":"Treatment of Helicobacter pylori infection: A clinical practice update","volume":"112","author":"Zagari","year":"2021","journal-title":"Minerva Med."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Aiba, Y., Ishikawa, H., Tokunaga, M., and Komatsu, Y. (2017). Anti-Helicobacter pylori activity of non-living, heat-killed form of lactobacilli including Lactobacillus johnsonii No.1088. FEMS Microbiol. Lett., 364.","DOI":"10.1093\/femsle\/fnx102"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3920\/BM2017.0002","article-title":"Opposing effect of Lactobacillus on in vitro Klebsiella pneumoniae in biofilm and in an in vivo intestinal colonisation model","volume":"9","author":"Lagrafeuille","year":"2018","journal-title":"Benef. Microbes"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.micinf.2015.10.008","article-title":"Control of Klebsiella pneumoniae pulmonary infection and immunomodulation by oral treatment with the commensal probiotic Bifidobacterium longum 51A","volume":"18","author":"Vieira","year":"2016","journal-title":"Microbes Infect."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.foodchem.2014.05.067","article-title":"Anticandidal activity of cell extracts from 13 probiotic Lactobacillus strains and characterisation of lactic acid and a novel fatty acid derivative from one strain","volume":"164","author":"Nyanzi","year":"2014","journal-title":"Food Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s12010-016-2014-y","article-title":"Purification, Characterization, and Optimum Conditions of Fermencin SD11, a Bacteriocin Produced by Human Orally Lactobacillus fermentum SD11","volume":"179","author":"Wannun","year":"2016","journal-title":"Appl. Biochem. Biotechnol."},{"key":"ref_46","first-page":"743","article-title":"Inhibitory effects of different lactobacilli on Candida albicans hyphal formation and biofilm development","volume":"28","author":"Orsi","year":"2014","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Itapary Dos Santos, C., Ramos Fran\u00e7a, Y., Duarte Lima Campos, C., Quaresma Bomfim, M.R., Oliveira Melo, B., Assun\u00e7\u00e3o Holanda, R., Santos, V.L., Gomes Monteiro, S., Buozzi Moffa, E., and Souza Monteiro, A. (2019). Antifungal and Antivirulence Activity of Vaginal Lactobacillus Spp. Products against Candida Vaginal Isolates. Pathogens, 8.","DOI":"10.3390\/pathogens8030150"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/jam.13324","article-title":"Lactobacillus rhamnosus inhibits Candida albicans virulence factors in vitro and modulates immune system in Galleria mellonella","volume":"122","author":"Ribeiro","year":"2017","journal-title":"J. Appl. Microbiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.anaerobe.2015.05.009","article-title":"In vitro modulation of probiotic bacteria on the biofilm of Candida glabrata","volume":"34","author":"Chew","year":"2015","journal-title":"Anaerobe"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Krzy\u015bciak, W., Ko\u015bcielniak, D., Papie\u017c, M., Vyhouskaya, P., Zag\u00f3rska-\u015awie\u017cy, K., Ko\u0142odziej, I., Bystrowska, B., and Jurczak, A. (2017). Effect of a Lactobacillus Salivarius Probiotic on a Double-Species Streptococcus Mutans and Candida Albicans Caries Biofilm. Nutrients, 9.","DOI":"10.3390\/nu9111242"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Rossoni, R.D., Fuchs, B.B., de Barros, P.P., Velloso, M.D., Jorge, A.O., Junqueira, J.C., and Mylonakis, E. (2017). Lactobacillus paracasei modulates the immune system of Galleria mellonella and protects against Candida albicans infection. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0173332"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Liao, H., Liu, S., Wang, H., Su, H., and Liu, Z. (2019). Enhanced antifungal activity of bovine lactoferrin-producing probiotic Lactobacillus casei in the murine model of vulvovaginal candidiasis. BMC Microbiol., 19.","DOI":"10.1186\/s12866-018-1370-x"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijwd.2015.02.001","article-title":"The effect of probiotics on immune regulation, acne, and photoaging","volume":"1","author":"Kober","year":"2015","journal-title":"Int. J. Women\u2019s Dermatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/exd.13504","article-title":"A topical treatment containing heat-treated Lactobacillus johnsonii NCC 533 reduces Staphylococcus aureus adhesion and induces antimicrobial peptide expression in an in vitro reconstructed human epidermis model","volume":"27","author":"Rosignoli","year":"2018","journal-title":"Exp. Dermatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jamadermatol.2017.3647","article-title":"Effect of Oral Administration of a Mixture of Probiotic Strains on SCORAD Index and Use of Topical Steroids in Young Patients With Moderate Atopic Dermatitis: A Randomized Clinical Trial","volume":"154","year":"2018","journal-title":"JAMA Dermatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1034\/j.1600-0625.2003.00051.x","article-title":"Effect of the lactic acid bacterium Streptococcus thermophilus on stratum corneum ceramide levels and signs and symptoms of atopic dermatitis patients","volume":"12","author":"Centi","year":"2003","journal-title":"Exp. Dermatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/CCID.S135529","article-title":"Effect of a lotion containing the heat-treated probiotic strain Lactobacillus johnsonii NCC 533 on Staphylococcus aureus colonization in atopic dermatitis","volume":"10","author":"Mercenier","year":"2017","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/exd.14032","article-title":"The role of topical probiotics in skin conditions: A systematic review of animal and human studies and implications for future therapies","volume":"29","author":"Knackstedt","year":"2020","journal-title":"Exp. Dermatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.micres.2009.11.008","article-title":"Antibacterial activity of Lactobacillus acidophilus and Lactobacillus casei against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"165","author":"Bazo","year":"2010","journal-title":"Microbiol. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"8851","DOI":"10.1016\/j.biortech.2010.06.104","article-title":"Structural characterization of a novel xylolipid biosurfactant from Lactococcus lactis and analysis of antibacterial activity against multi-drug resistant pathogens","volume":"101","author":"Saravanakumari","year":"2010","journal-title":"Bioresour. Technol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Bhola, J., and Bhadekar, R. (2019). Invitro synergistic activity of lactic acid bacteria against multi-drug resistant staphylococci. BMC Complement. Altern. Med., 19.","DOI":"10.1186\/s12906-019-2470-3"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s11274-011-0958-1","article-title":"Characterization and purification of a bacteriocin from Lactobacillus paracasei subsp. paracasei BMK2005, an intestinal isolate active against multidrug-resistant pathogens","volume":"28","author":"Bendjeddou","year":"2012","journal-title":"World J. Microbiol. Biotechnol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1099\/jmm.0.052639-0","article-title":"Synergistic antibacterial efficacies of the combination of bovine lactoferrin or its hydrolysate with probiotic secretion in curbing the growth of meticillin-resistant Staphylococcus aureus","volume":"62","author":"Chen","year":"2013","journal-title":"J. Med. Microbiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/mmi.13634","article-title":"Staphylococcus aureus biofilm: A complex developmental organism","volume":"104","author":"Moormeier","year":"2017","journal-title":"Mol. Microbiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12223-008-0009-y","article-title":"The influence of Lactobacillus acidophilus-derived surfactants on staphylococcal adhesion and biofilm formation","volume":"53","author":"Walencka","year":"2008","journal-title":"Folia Microbiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.apjtb.2017.10.013","article-title":"Influence of biofilm-forming lactic acid bacteria against methicillin-resistant Staphylococcus aureus (MRSA S547)","volume":"7","author":"Kumar","year":"2017","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Kranjec, C., Ovchinnikov, K.V., Gr\u00f8nseth, T., Ebineshan, K., Srikantam, A., and Diep, D.B. (2020). A bacteriocin-based antimicrobial formulation to effectively disrupt the cell viability of methicillin-resistant Staphylococcus aureus (MRSA) biofilms. Npj Biofilms Microbiomes, 6.","DOI":"10.1038\/s41522-020-00166-4"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Salman, M.K., Abuqwider, J., and Mauriello, G. (2023). Anti-Quorum Sensing Activity of Probiotics: The Mechanism and Role in Food and Gut Health. Microorganisms, 11.","DOI":"10.3390\/microorganisms11030793"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12934-021-01592-5","article-title":"Bacillus subtilis revives conventional antibiotics against Staphylococcus aureus osteomyelitis","volume":"20","author":"Zhang","year":"2021","journal-title":"Microb. Cell Factories"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.26443\/mjm.v18i1.156","article-title":"The role of probiotics in inhibition mechanism of methicillin-resistant Staphylococcus aureus","volume":"18","author":"Abbasi","year":"2020","journal-title":"McGill J. Med."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Jayashree, S., Karthikeyan, R., Nithyalakshmi, S., Ranjani, J., Gunasekaran, P., and Rajendhran, J. (2018). Anti-adhesion Property of the Potential Probiotic Strain Lactobacillus fermentum 8711 against Methicillin-Resistant Staphylococcus aureus (MRSA). Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.00411"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Mokoena, M.P. (2017). Lactic Acid Bacteria and Their Bacteriocins: Classification, Biosynthesis and Applications against Uropathogens: A Mini-Review. Molecules, 22.","DOI":"10.3390\/molecules22081255"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"8495","DOI":"10.1073\/pnas.1201263109","article-title":"Dermatophytic defensin with antiinfective potential","volume":"109","author":"Zhu","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s00284-017-1375-y","article-title":"Synergistic Antimicrobial Activity Between the Broad Spectrum Bacteriocin Garvicin KS and Nisin, Farnesol and Polymyxin B against Gram-Positive and Gram-Negative Bacteria","volume":"75","author":"Chi","year":"2018","journal-title":"Curr. Microbiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1128\/AEM.01094-16","article-title":"Novel Group of Leaderless Multipeptide Bacteriocins from Gram-Positive Bacteria","volume":"82","author":"Ovchinnikov","year":"2016","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Al Atya, A.K., Belguesmia, Y., Chataigne, G., Ravallec, R., Vach\u00e9e, A., Szunerits, S., Boukherroub, R., and Drider, D. (2016). Anti-MRSA Activities of Enterocins DD28 and DD93 and Evidences on Their Role in the Inhibition of Biofilm Formation. Front. Microbiol., 7.","DOI":"10.3389\/fmicb.2016.00817"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1038\/s41598-023-31185-8","article-title":"Development of novel broad-spectrum antimicrobial lipopeptides derived from plantaricin NC8 \u03b2","volume":"13","author":"Wiman","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Chanthasena, P., Hua, Y., Rosyidah, A., Pathom-Aree, W., Limphirat, W., and Nantapong, N. (2022). Isolation and Identification of Bioactive Compounds from Streptomyces actinomycinicus PJ85 and Their In Vitro Antimicrobial Activities against Methicillin-Resistant Staphylococcus aureus. Antibiotics, 11.","DOI":"10.3390\/antibiotics11121797"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e00945-22","DOI":"10.1128\/spectrum.00945-22","article-title":"Four Novel Leaderless Bacteriocins, Bacin A1, A2, A3, and A4 Exhibit Potent Antimicrobial and Antibiofilm Activities against Methicillin-Resistant Staphylococcus aureus","volume":"10","author":"Liu","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s12602-022-09954-0","article-title":"Anti-adhesion and Anti-inflammatory Potential of the Leaderless Class IIb Bacteriocin Enterocin DD14","volume":"14","author":"Teiar","year":"2022","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1432-1033.1991.tb16317.x","article-title":"Identification and characterization of the lantibiotic nisin Z, a natural nisin variant","volume":"201","author":"Mulders","year":"1991","journal-title":"Eur. J. Biochem."},{"key":"ref_82","first-page":"e00639-19","article-title":"Nisin J, a Novel Natural Nisin Variant, Is Produced by Staphylococcus capitis Sourced from the Human Skin Microbiota","volume":"202","author":"Rea","year":"2020","journal-title":"J. Bacteriol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/jac\/dkh387","article-title":"Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model","volume":"54","author":"Kruszewska","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Jiang, H., Zou, J., Cheng, H., Fang, J., and Huang, G. (2017). Purification, Characterization, and Mode of Action of Pentocin JL-1, a Novel Bacteriocin Isolated from Lactobacillus pentosus, against Drug-Resistant Staphylococcus aureus. Biomed Res. Int., 2017.","DOI":"10.1155\/2017\/7657190"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Ansari, A., Zohra, R.R., Tarar, O.M., Qader, S.A.U., and Aman, A. (2018). Screening, purification and characterization of thermostable, protease resistant Bacteriocin active against methicillin resistant Staphylococcus aureus (MRSA). BMC Microbiol., 18.","DOI":"10.1186\/s12866-018-1337-y"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2217\/fmb-2016-0113","article-title":"Inhibition of MRSA and of Clostridium difficile by durancin 61A: Synergy with bacteriocins and antibiotics","volume":"12","author":"Hanchi","year":"2017","journal-title":"Future Microbiol."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Taggar, R., Singh, S., Bhalla, V., Bhattacharyya, M.S., and Sahoo, D.K. (2021). Deciphering the Antibacterial Role of Peptide From Bacillus subtilis subsp. spizizenii Ba49 against Staphylococcus aureus. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.708712"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.3390\/md11061878","article-title":"Subtilomycin: A New Lantibiotic from Bacillus subtilis Strain MMA7 Isolated from the Marine Sponge Haliclona simulans","volume":"11","author":"Phelan","year":"2013","journal-title":"Mar. Drugs"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1021\/np500424y","article-title":"Class I and Class II Lanthipeptides Produced by Bacillus spp.","volume":"78","author":"Barbosa","year":"2015","journal-title":"J. Nat. Prod."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1128\/AAC.05397-11","article-title":"Identification, characterization, and recombinant expression of epidermicin NI01, a novel unmodified bacteriocin produced by Staphylococcus epidermidis that displays potent activity against Staphylococci","volume":"56","author":"Sandiford","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e00954-22","DOI":"10.1128\/spectrum.00954-22","article-title":"Identification of a Novel Two-Peptide Lantibiotic from Vagococcus fluvialis","volume":"10","author":"Thiyagarajah","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1128\/AEM.02150-07","article-title":"Capacity of Human Nisin- and Pediocin-Producing Lactic Acid Bacteria To Reduce Intestinal Colonization by Vancomycin-Resistant Enterococci","volume":"74","author":"Millette","year":"2008","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Li, X., Song, L., Zhu, S., Xiao, Y., Huang, Y., Hua, Y., Chu, Q., and Ren, Z. (2019). Two Strains of Lactobacilli Effectively Decrease the Colonization of VRE in a Mouse Model. Front. Cell. Infect. Microbiol., 9.","DOI":"10.3389\/fcimb.2019.00006"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Phumisantiphong, U., Siripanichgon, K., Reamtong, O., and Diraphat, P. (2017). A novel bacteriocin from Enterococcus faecalis 478 exhibits a potent activity against vancomycin-resistant enterococci. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0186415"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Ovchinnikov, K.V., Kristiansen, P.E., Straume, D., Jensen, M.S., Aleksandrzak-Piekarczyk, T., Nes, I.F., and Diep, D.B. (2017). The Leaderless Bacteriocin Enterocin K1 Is Highly Potent against Enterococcus faecium: A Study on Structure, Target Spectrum and Receptor. Front. Microbiol., 8.","DOI":"10.3389\/fmicb.2017.00774"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Plupjeen, S.N., Chawjiraphan, W., Charoensiddhi, S., Nitisinprasert, S., and Nakphaichit, M. (2020). Lactococcus lactis KA-FF 1-4 reduces vancomycin-resistant enterococci and impacts the human gut microbiome. 3 Biotech, 10.","DOI":"10.1007\/s13205-020-02282-6"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Li, M., Lee, K., Hsu, M., Nau, G., Mylonakis, E., and Ramratnam, B. (2017). Lactobacillus-derived extracellular vesicles enhance host immune responses against vancomycin-resistant enterococci. BMC Microbiol., 17.","DOI":"10.1186\/s12866-017-0977-7"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Bucheli, J.E.V., Fugaban, J.I.I., Holzapfel, W.H., and Todorov, S.D. (2022). Combined Action of Antibiotics and Bacteriocins against Vancomycin-Resistant Enterococci. Microorganisms, 10.","DOI":"10.3390\/microorganisms10071423"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jgar.2020.02.031","article-title":"Effect of the lantibiotic nisin on inhibitory and bactericidal activities of antibiotics used against vancomycin-resistant enterococci","volume":"22","year":"2020","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Sun, W.S., Lee, Y.J., Tsai, K.N., Ho, Y.H., and Fang, S.B. (2020). Probiotic Cocktail Identified by Microbial Network Analysis Inhibits Growth, Virulence Gene Expression, and Host Cell Colonization of Vancomycin-Resistant Enterococci. Microorganisms, 8.","DOI":"10.3390\/microorganisms8060816"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2672.2006.03044.x","article-title":"Partial characterization of bacteriocins produced by human Lactococcus lactis and Pediococccus acidilactici isolates","volume":"102","author":"Millette","year":"2007","journal-title":"J. Appl. Microbiol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"106394","DOI":"10.1016\/j.isci.2023.106394","article-title":"Dual targeting of the class V lanthipeptide antibiotic cacaoidin","volume":"26","author":"Deisinger","year":"2023","journal-title":"iScience"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Mousa, W.K., Ghemrawi, R., Abu-Izneid, T., Ramadan, A., and Al-Marzooq, F. (2023). Discovery of Lactomodulin, a Unique Microbiome-Derived Peptide That Exhibits Dual Anti-Inflammatory and Antimicrobial Activity against Multidrug-Resistant Pathogens. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24086901"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Sharma, M., and Manhas, R.K. (2019). Purification and characterization of actinomycins from Streptomyces strain M7 active against methicillin resistant Staphylococcus aureus and vancomycin resistant Enterococcus. BMC Microbiol., 19.","DOI":"10.1186\/s12866-019-1405-y"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s00284-006-0632-2","article-title":"Pumilicin 4, a novel bacteriocin with anti-MRSA and anti-VRE activity produced by newly isolated bacteria Bacillus pumilus strain WAPB4","volume":"55","author":"Aunpad","year":"2007","journal-title":"Curr. Microbiol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nature04051","article-title":"Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus","volume":"437","author":"Mygind","year":"2005","journal-title":"Nature"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1089\/mdr.2014.0221","article-title":"Antimicrobial Activity of Plectasin NZ2114 in Combination with Cell Wall Targeting Antibiotics against VanA-Type Enterococcus faecalis","volume":"21","author":"Breidenstein","year":"2015","journal-title":"Microb. Drug Resist."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1128\/AAC.00453-11","article-title":"Efficacy of NZ2114, a novel plectasin-derived cationic antimicrobial peptide antibiotic, in experimental endocarditis due to methicillin-resistant Staphylococcus aureus","volume":"55","author":"Xiong","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1038\/s41598-017-03769-8","article-title":"Neo-actinomycins A and B, natural actinomycins bearing the 5H-oxazolo[4,5-b]phenoxazine chromophore, from the marine-derived Streptomyces sp. IMB094","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2217\/fmb-2019-0153","article-title":"Nisin Z and lacticin 3147 improve efficacy of antibiotics against clinically significant bacteria","volume":"14","author":"Ellis","year":"2019","journal-title":"Future Microbiol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.5851\/kosfa.2018.e40","article-title":"Antimicrobial Activity of a Bacteriocin Produced by Enterococcus faecalis KT11 against Some Pathogens and Antibiotic-Resistant Bacteria","volume":"38","author":"Abanoz","year":"2018","journal-title":"Korean J. Food Sci. Anim. Resour."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.peptides.2017.11.009","article-title":"Invasive fungi-derived defensins kill drug-resistant bacterial pathogens","volume":"99","author":"Wu","year":"2018","journal-title":"Peptides"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13568-016-0315-8","article-title":"Glycin-rich antimicrobial peptide YD1 from B. amyloliquefaciens, induced morphological alteration in and showed affinity for plasmid DNA of E. coli","volume":"7","author":"Rahman","year":"2017","journal-title":"AMB Express"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1128\/AEM.03751-13","article-title":"Cerecidins, novel lantibiotics from Bacillus cereus with potent antimicrobial activity","volume":"80","author":"Wang","year":"2014","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"bcr2012006366","DOI":"10.1136\/bcr-2012-006366","article-title":"Enteral vancomycin and probiotic use for methicillin-resistant Staphylococcus aureus antibiotic-associated diarrhoea","volume":"2012","author":"Sizemore","year":"2012","journal-title":"BMJ Case Rep."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.amjsurg.2010.02.013","article-title":"Perioperative synbiotic treatment to prevent infectious complications in patients after elective living donor liver transplantation: A prospective randomized study","volume":"201","author":"Eguchi","year":"2011","journal-title":"Am. J. Surg."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jhin.2011.01.010","article-title":"Can probiotic lactobacilli eradicate persistent carriage of meticillin-resistant Staphylococcus aureus?","volume":"78","author":"Roos","year":"2011","journal-title":"J. Hosp. Infect."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3920\/BM2013.0062","article-title":"Tolerability of a probiotic in subjects with a history of methicillin-resistant Staphylococcus aureus colonisation","volume":"5","author":"Warrack","year":"2014","journal-title":"Benef. Microbes"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Eggers, S., Barker, A.K., Valentine, S., Hess, T., Duster, M., and Safdar, N. (2018). Effect of Lactobacillus rhamnosus HN001 on carriage of Staphylococcus aureus: Results of the impact of probiotics for reducing infections in veterans (IMPROVE) study. BMC Infect. Dis., 18.","DOI":"10.1186\/s12879-018-3028-6"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1016\/S2666-5247(22)00322-6","article-title":"Probiotic for pathogen-specific Staphylococcus aureus decolonisation in Thailand: A phase 2, double-blind, randomised, placebo-controlled trial","volume":"4","author":"Piewngam","year":"2023","journal-title":"Lancet Microbe"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"454","DOI":"10.5694\/j.1326-5377.2007.tb00995.x","article-title":"Probiotic treatment of vancomycin-resistant enterococci: A randomised controlled trial","volume":"186","author":"Manley","year":"2007","journal-title":"Med. J. Aust."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Cheng, V.C., Chen, J.H., Tai, J.W., Wong, S.C., Poon, R.W., Hung, I.F., To, K.K., Chan, J.F., Ho, P.L., and Lo, C.M. (2014). Decolonization of gastrointestinal carriage of vancomycin-resistant Enterococcus faecium: Case series and review of literature. BMC Infect. Dis., 14.","DOI":"10.1186\/1471-2334-14-514"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1080\/14767058.2020.1743671","article-title":"A new use of Lactobacillus rhamnosus GG administration in the NICU: Colonized vancomycin-resistant enterococcus eradication in the gastrointestinal system","volume":"35","author":"Buyukeren","year":"2022","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1097\/MCG.0b013e318227439f","article-title":"An Evaluation of the Ability of the Probiotic Strain Lactobacillus rhamnosus GG to Eliminate the Gastrointestinal Carrier State of Vancomycin-resistant Enterococci in Colonized Children","volume":"45","author":"Szachta","year":"2011","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1128\/JCM.00473-10","article-title":"Probiotics and intestinal colonization by vancomycin-resistant enterococci in mice and humans","volume":"48","author":"Vidal","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1128\/AAC.00300-15","article-title":"Effect of Lactobacillus rhamnosus GG Administration on Vancomycin-Resistant Enterococcus Colonization in Adults with Comorbidities","volume":"59","author":"Doron","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1017\/ice.2021.94","article-title":"A randomized controlled trial of Lactobacillus rhamnosus GG on antimicrobial-resistant organism colonization","volume":"43","author":"Rauseo","year":"2022","journal-title":"Infect. Control. Hosp. Epidemiol."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Rubin, I.M.C., Mollerup, S., Broholm, C., Knudsen, S.B., Baker, A., Helms, M., Holm, M.K.A., Kallemose, T., Westh, H., and Dahl Knudsen, J. (2022). No Effect of Lactobacillus rhamnosus GG on Eradication of Colonization by Vancomycin-Resistant Enterococcus faecium or Microbiome Diversity in Hospitalized Adult Patients. Microbiol. Spectr., 10.","DOI":"10.1128\/spectrum.02348-21"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1128\/AAC.01765-09","article-title":"Effects of probiotics on acquisition and spread of multiresistant enterococci","volume":"54","author":"Willems","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2147\/TCRM.S179208","article-title":"Treatment with Saccharomyces boulardii and Escherichia coli Nissle is safe and associated with reduced nosocomial transmission of van B vancomycin-resistant Enterococcus faecium on an early rehabilitation ward in Germany: A retrospective analysis","volume":"15","author":"Borgmann","year":"2019","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1086\/523339","article-title":"Probiotics in the United States","volume":"46","author":"Vanderhoof","year":"2008","journal-title":"Clin. Infect. Dis.Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/s41591-019-0439-x","article-title":"The pros, cons, and many unknowns of probiotics","volume":"25","author":"Suez","year":"2019","journal-title":"Nat. Med."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Dom\u00ednguez Rubio, A.P., D\u2019Antoni, C.L., Piuri, M., and P\u00e9rez, O.E. (2022). Probiotics, Their Extracellular Vesicles and Infectious Diseases. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.864720"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"\u00d1ahui Palomino, R.A., Vanpouille, C., Costantini, P.E., and Margolis, L. (2021). Microbiota\u2013host communications: Bacterial extracellular vesicles as a common language. PLOS Pathog., 17.","DOI":"10.1371\/journal.ppat.1009508"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"2185034","DOI":"10.1080\/19490976.2023.2185034","article-title":"Emerging issues in probiotic safety: 2023 perspectives","volume":"15","author":"Merenstein","year":"2023","journal-title":"Gut Microbes"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1006\/plas.1996.0039","article-title":"Molecular characterization of a plasmid-borne (pTC82) chloramphenicol resistance determinant (cat-TC) from Lactobacillus reuteriG4","volume":"36","author":"Lin","year":"1996","journal-title":"Plasmid"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1006\/plas.1994.1007","article-title":"Molecular characterization of a plasmid-borne (pGT633) erythromycin resistance determinant (ermGT) from Lactobacillus reuteri 100-63","volume":"31","author":"Tannock","year":"1994","journal-title":"Plasmid"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1016\/j.immuni.2021.10.012","article-title":"The immunology of sepsis","volume":"54","author":"Wiersinga","year":"2021","journal-title":"Immunity"},{"key":"ref_139","first-page":"56","article-title":"Sepsis-induced immunosuppression: Mechanisms, diagnosis and current treatment options","volume":"9","author":"Liu","year":"2022","journal-title":"Mil. Med. Res."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"e1302","DOI":"10.1093\/cid\/ciaa1189","article-title":"Immunosuppressive Agents and Infectious Risk in Transplantation: Managing the \u201cNet State of Immunosuppression\u201d","volume":"73","author":"Roberts","year":"2021","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cytogfr.2021.01.006","article-title":"Hallmarks of aging and immunosenescence: Connecting the dots","volume":"59","author":"Rodrigues","year":"2021","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Simons, A., Alhanout, K., and Duval, R.E. (2020). Bacteriocins, Antimicrobial Peptides from Bacterial Origin: Overview of Their Biology and Their Impact against Multidrug-Resistant Bacteria. Microorganisms, 8.","DOI":"10.3390\/microorganisms8050639"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/138920109787048616","article-title":"Lantibiotics: Mode of action, biosynthesis and bioengineering","volume":"10","author":"Bierbaum","year":"2009","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Sass, P., Jansen, A., Szekat, C., Sass, V., Sahl, H.-G., and Bierbaum, G. (2008). The lantibiotic mersacidin is a strong inducer of the cell wall stress response of Staphylococcus aureus. BMC Microbiol., 8.","DOI":"10.1186\/1471-2180-8-186"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0065-2164(04)54005-4","article-title":"Colicins and microcins: The next generation antimicrobials","volume":"54","author":"Gillor","year":"2004","journal-title":"Adv. Appl. Microbiol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1080\/07388551.2020.1796576","article-title":"Antimicrobial peptides as therapeutic agents: Opportunities and challenges","volume":"40","author":"Mahlapuu","year":"2020","journal-title":"Crit. Rev. Biotechnol."}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/11\/10\/2393\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:57:54Z","timestamp":1760129874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/11\/10\/2393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,25]]},"references-count":146,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["microorganisms11102393"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms11102393","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,25]]}}}